Cutting-edge issues in celiac disease and in gluten intolerance (Q37823418)

23 August 2017

1 reference

title

Cutting-edge issues in celiac disease and in gluten intolerance (English)

1 reference

23 August 2017

1

N Bizzaro

1 reference

23 August 2017

R Tozzoli

2

1 reference

23 August 2017

D Villalta

series ordinal

3

1 reference

23 August 2017

M Fabris

series ordinal

4

1 reference

23 August 2017

E Tonutti

series ordinal

5

1 reference

23 August 2017

1 June 2012

1 reference

Clinical Reviews in Allergy & Immunology

23 August 2017

1 reference

23 August 2017

42

1 reference

23 August 2017

3

1 reference

23 August 2017

279-287

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-010-8223-1

23 August 2017

0 references

cites work

Coeliac disease in the year 2000: exploring the iceberg

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

The diagnostic accuracy of serologic tests for celiac disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Autoantibodies to tissue transglutaminase as predictors of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: a French-Italian multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Serological screening for celiac disease in healthy 2.5-year-old children in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Comparison of commercially available serologic kits for the detection of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Immune reaction against the cytoskeleton in coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Transglutaminase 2 undergoes a large conformational change upon activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

High prevalence of celiac disease in Mexican Mestizo adults with type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Diagnostic accuracy of coeliac serological tests: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity"

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Intolerance to cereals is not specific for coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Is this really celiac disease? Pitfalls in diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Myopathy associated with gluten sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

The gluten syndrome: a neurological disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

The gluten-free, casein-free diet in autism: an overview with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Innate T cell responses in human gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Gliadin as a stimulator of innate responses in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Celiac disease: from pathogenesis to novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

The cytokine interleukin 21: a new player in coeliac disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Celiac disease and TNF promoter polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Where Is Celiac Disease Coming From and Why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Current concepts of celiac disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Celiac disease pathogenesis: the proinflammatory cytokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

BLyS and APRIL in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

BAFF mediates survival of peripheral immature B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Serum cytokine elevations in celiac disease: association with disease presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Anti-actin IgA antibodies in severe coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Celiac Disease Could be a Frequent Disease in Mexico: Prevalence of Tissue Transglutaminase Antibody in Healthy Blood Donors

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

21 January 2018

12 December 2020

Enterocyte Actin Autoantibody Detection: A New Diagnostic Tool in Celiac Disease Diagnosis: Results of a Multicenter Study

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Natural history of celiac disease autoimmunity in a USA cohort followed since 1974

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

B-Lymphocyte Stimulator and a Proliferation-Inducing Ligand Serum Levels in IgA-Deficient Patients With and Without Celiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8223-1

Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age

21 January 2018

1 reference

12 December 2020

Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age

1 reference

12 December 2020

The role of BAFF in B-cell maturation, T-cell activation and autoimmunity

1 reference

12 December 2020

Heterogeneity of celiac disease: clinical, pathological, immunological, and genetic

1 reference

12 December 2020

Natural History of Antibodies to Deamidated Gliadin Peptides and Transglutaminase in Early Childhood Celiac Disease

1 reference

12 December 2020

Gliadin peptides activate blood monocytes from patients with celiac disease

1 reference

12 December 2020

Increased serum IL-2R levels in coeliac disease are related to CD4 but not CD8 antigens

1 reference

12 December 2020

1 reference

12 December 2020

Endomysial and tissue transglutaminase antibodies in coeliac sera: a comparison not influenced by previous serological testing

1 reference

12 December 2020

The generation of T cell tolerance

1 reference

12 December 2020

Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease

1 reference

12 December 2020

Increased serum levels of interleukin-2 and soluble interleukin-2 receptor in celiac disease

1 reference

12 December 2020

Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease

1 reference

12 December 2020

Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease

1 reference

12 December 2020

Human oesophagus: a convenient antigenic substrate for the determination of anti-endomysium antibodies in the serological diagnosis of coeliac disease

1 reference

12 December 2020

Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit

1 reference

12 December 2020

Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition

1 reference

12 December 2020

Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease

1 reference

12 December 2020

Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay

1 reference

12 December 2020

Celiac disease without villous atrophy in children: a prospective study

1 reference

12 December 2020

Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.

1 reference

12 December 2020

Interleukin 18 maintains a long-standing inflammation in coeliac disease patients

1 reference

12 December 2020

Synthesis and release of B-lymphocyte stimulator from myeloid cells

1 reference

12 December 2020

Increasing prevalence of coeliac disease over time

1 reference

12 December 2020

Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: a 2-year prospective study

1 reference

12 December 2020

10.1007/S12016-010-8223-1

Identifiers

DOI

1 reference

23 August 2017

1 reference